12. Subsequent Events	6 Months Ended
Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events	12. SUBSEQUENT EVENTS In July 2017, the Company granted a total of 1,900,000 of common shares for services provided to Company executives and other consultants at $0.00 per share. The Company has recorded the expense at a value of $150,666. In August 2017, the Company sold 500,000 shares at $0.50 per share, 300,000 shares at $0.75 per share, 300,000 shares at $1.00 per share and 50,000 shares at $1.25 per share for a total cash amount of $837,500. On November 20, 2017, the Plan was amended to increase the maximum number of shares of stock that may be issued to 3,500,000. On February 9, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 4,500,000. On March 18, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 5,000,000. As of the date of this report, options to acquire 4,543,083 shares of stock have been granted, with exercise prices ranging from $0.00 to $1.50 per share. In December 2017, the Company issued a total of 7,500,000 common shares for services provided to Company executives and other consultants at $0.00 per share. The Company has recorded the expense at a value of approximately $465,000. Effective December 31, 2017, the Company issued a total of 3,877,931 common shares as settlement of all outstanding convertible debt instruments, having principal and accrued interest totaling $3,631,460. The conversion of the outstanding debt and accrued interest cured the events of default under such debt instruments. Effective December 31, 2017, the Company issued a total of 2,375,000 common shares as settlement for warrants exercised for a total cash amount of $1,187,500. Effective December 31, 2017, the Company issued a total of 126,668 common shares as settlement for options exercised for a total cash amount of $190,000. On December 22, 2017, the Tax Cuts and Jobs Act (the “Act”) was signed into United States tax law, which among other provisions will lower the corporate tax rate to 21%. Given this date of enactment, the Company’s financial statements as of and for the period ended June 30, 2017 do not reflect the impact of the Act. The Company is in the process of analyzing the potential aggregate impact of the Act and will reflect any such impact in the quarterly report for the period in which the law was enacted. On January 3, 2018, 80,000 warrants were exercised at $.50 per share for a total cash amount of $40,000. On February 9, 2018, the expiration date of the remaining warrants was extended to December 31, 2018. On February 28, 2018, the Company sold 33,333 common shares at $1.50 per share for a total cash amount of $50,000. On March 2, 2018, the Company sold 16,500 common shares at $1.50 per share for a total cash amount of $24,750. On March 14, 2018, the Company sold 50,000 common shares at $1.50 per share for a total cash amount of $75,000. On March 16, 2018, the Company sold 10,000 common shares at $1.50 per share for a total cash amount of $15,000. On March 19, 2018, the Company sold 100,000 common shares at $1.50 per share for a total cash amount of $150,000. On April 2, 2018, the Company sold 34,000 common shares at $1.50 per share for a total cash amount of $51,000. On April 13, 2018, the Company sold 13,400 common shares at $1.50 per share for a total cash amount of $20,100.

12. Subsequent Events

6 Months Ended

Jun. 30, 2017

12. SUBSEQUENT EVENTS

In July 2017, the Company granted a total of 1,900,000 of common shares for services provided to Company executives and other consultants at $0.00 per share. The Company has recorded the expense at a value of $150,666.

In August 2017, the Company sold 500,000 shares at $0.50 per share, 300,000 shares at $0.75 per share, 300,000 shares at $1.00 per share and 50,000 shares at $1.25 per share for a total cash amount of $837,500.

On November 20, 2017, the Plan was amended to increase the maximum number of shares of stock that may be issued to 3,500,000. On February 9, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 4,500,000. On March 18, 2018, the Plan was amended to increase the maximum number of shares of stock that may be issued to 5,000,000. As of the date of this report, options to acquire 4,543,083 shares of stock have been granted, with exercise prices ranging from $0.00 to $1.50 per share.

In December 2017, the Company issued a total of 7,500,000 common shares for services provided to Company executives and other consultants at $0.00 per share. The Company has recorded the expense at a value of approximately $465,000.

Effective December 31, 2017, the Company issued a total of 3,877,931 common shares as settlement of all outstanding convertible debt instruments, having principal and accrued interest totaling $3,631,460. The conversion of the outstanding debt and accrued interest cured the events of default under such debt instruments.

Effective December 31, 2017, the Company issued a total of 2,375,000 common shares as settlement for warrants exercised for a total cash amount of $1,187,500.

Effective December 31, 2017, the Company issued a total of 126,668 common shares as settlement for options exercised for a total cash amount of $190,000.

On December 22, 2017, the Tax Cuts and Jobs Act (the “Act”) was signed into United States tax law, which among other provisions will lower the corporate tax rate to 21%. Given this date of enactment, the Company’s financial statements as of and for the period ended June 30, 2017 do not reflect the impact of the Act. The Company is in the process of analyzing the potential aggregate impact of the Act and will reflect any such impact in the quarterly report for the period in which the law was enacted.

On January 3, 2018, 80,000 warrants were exercised at $.50 per share for a total cash amount of $40,000.

On February 9, 2018, the expiration date of the remaining warrants was extended to December 31, 2018.

On February 28, 2018, the Company sold 33,333 common shares at $1.50 per share for a total cash amount of $50,000.

On March 2, 2018, the Company sold 16,500 common shares at $1.50 per share for a total cash amount of $24,750.

On March 14, 2018, the Company sold 50,000 common shares at $1.50 per share for a total cash amount of $75,000.

On March 16, 2018, the Company sold 10,000 common shares at $1.50 per share for a total cash amount of $15,000.

On March 19, 2018, the Company sold 100,000 common shares at $1.50 per share for a total cash amount of $150,000.

On April 2, 2018, the Company sold 34,000 common shares at $1.50 per share for a total cash amount of $51,000.

On April 13, 2018, the Company sold 13,400 common shares at $1.50 per share for a total cash amount of $20,100.

Worldwide Specialty Chemicals Inc. 10-Q